R.M. Davis Inc’s GSK GSK Stock Holding History

R.M. Davis Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,940	Closed	-$268K	–	202
2016 Q2	$268K	Buy	4,940 +480	+11%	+$25.3K	0.01%	179
2016 Q1	$226K	Sell	4,460 -12	-0.3%	-$598	0.01%	184
2015 Q4	$226K	Sell	4,472 -148	-3%	-$7.54K	0.01%	185
2015 Q3	$222K	Buy	4,620 +160	+4%	+$8.33K	0.01%	184
2015 Q2	$232K	Hold	4,460	–	–	0.01%	177
2015 Q1	$257K	Hold	4,460	–	–	0.01%	170
2014 Q4	$238K	Hold	4,460	–	–	0.01%	171
2014 Q3	$256K	Sell	4,460 -480	-10%	-$29.4K	0.01%	168
2014 Q2	$330K	Sell	4,940 -25	-0.5%	-$1.69K	0.02%	154
2014 Q1	$332K	Hold	4,965	–	–	0.02%	151
2013 Q4	$331K	Buy	4,965 +25	+0.5%	+$1.62K	0.02%	151
2013 Q3	$310K	Sell	4,940 -480	-9%	-$30.9K	0.02%	150
2013 Q2	$339K	Buy	+5,420	New	+$344K	0.02%	141

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

R.M. Davis Inc's GSK Position: Q3 2016 in Review

R.M. Davis Inc sold out of GSK (GSK) in Q3 2016, closing a stake of 4,940 shares — an estimated $268K sold.

R.M. Davis Inc first reported a position in GSK in Q2 2013 and held it in 13 quarters. The position peaked at $339K in Q2 2013. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

R.M. Davis Inc reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
R.M. Davis Inc sold 4,940 GSK shares in Q3 2016, an estimated $268K.
R.M. Davis Inc first reported a position in GSK in Q2 2013 and held it in 13 quarters.
R.M. Davis Inc's GSK position peaked at $339K in Q2 2013.
740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on R.M. Davis Inc's 13F filing for Q3 2016, filed 19 Oct 2016.